Literature DB >> 18192269

Detergent-insoluble aggregates associated with amyotrophic lateral sclerosis in transgenic mice contain primarily full-length, unmodified superoxide dismutase-1.

Bryan F Shaw1, Herman L Lelie, Armando Durazo, Aram M Nersissian, Guillan Xu, Pik K Chan, Edith B Gralla, Ashutosh Tiwari, Lawrence J Hayward, David R Borchelt, Joan S Valentine, Julian P Whitelegge.   

Abstract

Determining the composition of aggregated superoxide dismutase 1 (SOD1) species associated with amyotrophic lateral sclerosis (ALS), especially with respect to co-aggregated proteins and post-translational modifications, could identify cellular or biochemical factors involved in the formation of these aggregates and explain their apparent neurotoxicity. The results of mass spectrometric and shotgun-proteomic analyses of SOD1-containing aggregates isolated from spinal cords of symptomatic transgenic ALS mice using two different isolation strategies are presented, including 1) resistance to detergent extraction and 2) size exclusion-coupled anti-SOD1 immunoaffinity chromatography. Forty-eight spinal cords from three different ALS-SOD1 mutant mice were analyzed, namely G93A, G37R, and the unnatural double mutant H46R/H48Q. The analysis consistently revealed that the most abundant proteins recovered from aggregate species were full-length unmodified SOD1 polypeptides. Although aggregates from some spinal cord samples contained trace levels of highly abundant proteins, such as vimentin and neurofilament-3, no proteins were consistently found to co-purify with mutant SOD1 in stoichiometric quantities. The results demonstrate that the principal protein in the high molecular mass aggregates whose appearance correlates with symptoms of the disease is the unmodified, full-length SOD1 polypeptide.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18192269      PMCID: PMC2276386          DOI: 10.1074/jbc.M707751200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  Decrease of Hsp25 protein expression precedes degeneration of motoneurons in ALS-SOD1 mice.

Authors:  Arjen Maatkamp; Angela Vlug; Elize Haasdijk; Dirk Troost; Pim J French; Dick Jaarsma
Journal:  Eur J Neurosci       Date:  2004-07       Impact factor: 3.386

2.  Subtle modification of isotope ratio proteomics; an integrated strategy for expression proteomics.

Authors:  Julian P Whitelegge; Jonathan E Katz; Katianna A Pihakari; Rebecca Hale; Rodrigo Aguilera; Stephen M Gómez; Kym F Faull; Dmitrii Vavilin; Willem Vermaas
Journal:  Phytochemistry       Date:  2004-06       Impact factor: 4.072

3.  Modification of cysteine 111 in Cu/Zn superoxide dismutase results in altered spectroscopic and biophysical properties.

Authors:  Mitchel D de Beus; Jinhyuk Chung; Wilfredo Colón
Journal:  Protein Sci       Date:  2004-05       Impact factor: 6.725

Review 4.  Do oxidatively modified proteins cause ALS?

Authors:  Joan Selverstone Valentine
Journal:  Free Radic Biol Med       Date:  2002-11-15       Impact factor: 7.376

5.  A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids.

Authors:  D Wessel; U I Flügge
Journal:  Anal Biochem       Date:  1984-04       Impact factor: 3.365

6.  Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement.

Authors:  N Shibata; A Hirano; M Kobayashi; T Siddique; H X Deng; W Y Hung; T Kato; K Asayama
Journal:  J Neuropathol Exp Neurol       Date:  1996-04       Impact factor: 3.685

7.  Co-chaperone CHIP associates with mutant Cu/Zn-superoxide dismutase proteins linked to familial amyotrophic lateral sclerosis and promotes their degradation by proteasomes.

Authors:  Jin-Sun Choi; Sayeon Cho; Sung Goo Park; Byoung Chul Park; Do Hee Lee
Journal:  Biochem Biophys Res Commun       Date:  2004-08-27       Impact factor: 3.575

8.  CHIP promotes proteasomal degradation of familial ALS-linked mutant SOD1 by ubiquitinating Hsp/Hsc70.

Authors:  Makoto Urushitani; Junko Kurisu; Minako Tateno; Shigetsugu Hatakeyama; Kei-Ichi Nakayama; Shinsuke Kato; Ryosuke Takahashi
Journal:  J Neurochem       Date:  2004-07       Impact factor: 5.372

9.  Familial amyotrophic lateral sclerosis with a two base pair deletion in superoxide dismutase 1: gene multisystem degeneration with intracytoplasmic hyaline inclusions in astrocytes.

Authors:  S Kato; M Shimoda; Y Watanabe; K Nakashima; K Takahashi; E Ohama
Journal:  J Neuropathol Exp Neurol       Date:  1996-10       Impact factor: 3.685

10.  Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria.

Authors:  Piera Pasinelli; Mary Elizabeth Belford; Niall Lennon; Brian J Bacskai; Bradley T Hyman; Davide Trotti; Robert H Brown
Journal:  Neuron       Date:  2004-07-08       Impact factor: 17.173

View more
  40 in total

1.  Strategies for stabilizing superoxide dismutase (SOD1), the protein destabilized in the most common form of familial amyotrophic lateral sclerosis.

Authors:  Jared R Auclair; Kristin J Boggio; Gregory A Petsko; Dagmar Ringe; Jeffrey N Agar
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

2.  Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition.

Authors:  Lorena Saelices; Kevin Chung; Ji H Lee; Whitaker Cohn; Julian P Whitelegge; Merrill D Benson; David S Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-28       Impact factor: 11.205

3.  Poloxamer 188 decreases membrane toxicity of mutant SOD1 and ameliorates pathology observed in SOD1 mouse model for ALS.

Authors:  Jacob J Riehm; Lijun Wang; Ghanashyam Ghadge; Michael Teng; Ana M Correa; Jeremy D Marks; Raymond P Roos; Michael J Allen
Journal:  Neurobiol Dis       Date:  2018-04-05       Impact factor: 5.996

4.  SOD1 mutations targeting surface hydrogen bonds promote amyotrophic lateral sclerosis without reducing apo-state stability.

Authors:  Roberth Byström; Peter M Andersen; Gerhard Gröbner; Mikael Oliveberg
Journal:  J Biol Chem       Date:  2010-02-26       Impact factor: 5.157

5.  Modulation of mutant superoxide dismutase 1 aggregation by co-expression of wild-type enzyme.

Authors:  Mercedes Prudencio; Armando Durazo; Julian P Whitelegge; David R Borchelt
Journal:  J Neurochem       Date:  2008-12-11       Impact factor: 5.372

6.  Changes in proteome solubility indicate widespread proteostatic disruption in mouse models of neurodegenerative disease.

Authors:  Michael C Pace; Guilian Xu; Susan Fromholt; John Howard; Keith Crosby; Benoit I Giasson; Jada Lewis; David R Borchelt
Journal:  Acta Neuropathol       Date:  2018-08-23       Impact factor: 17.088

7.  Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis.

Authors:  Ruth Chia; M Howard Tattum; Samantha Jones; John Collinge; Elizabeth M C Fisher; Graham S Jackson
Journal:  PLoS One       Date:  2010-05-13       Impact factor: 3.240

8.  DNA-triggered aggregation of copper, zinc superoxide dismutase in the presence of ascorbate.

Authors:  Jun Yin; Si Hu; Wei Jiang; Liang Liu; Shemin Lan; Xuegang Song; Changlin Liu
Journal:  PLoS One       Date:  2010-08-20       Impact factor: 3.240

Review 9.  Aggregation of copper-zinc superoxide dismutase in familial and sporadic ALS.

Authors:  Madhuri Chattopadhyay; Joan Selverstone Valentine
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

10.  Characterization of detergent-insoluble proteins in ALS indicates a causal link between nitrative stress and aggregation in pathogenesis.

Authors:  Manuela Basso; Giuseppina Samengo; Giovanni Nardo; Tania Massignan; Giuseppina D'Alessandro; Silvia Tartari; Lavinia Cantoni; Marianna Marino; Cristina Cheroni; Silvia De Biasi; Maria Teresa Giordana; Michael J Strong; Alvaro G Estevez; Mario Salmona; Caterina Bendotti; Valentina Bonetto
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.